Norges Bank Intellia Therapeutics, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$20.02 - $27.22 $4.81 Million - $6.54 Million	240,415 New	240,415 $5.38 Million
Q4 2023 Feb 09, 2024	BUY	$23.16 - $32.34 $12.4 Million - $17.3 Million	536,172 New	536,172 $16.3 Million
Q3 2023 Nov 13, 2024	BUY	$31.62 - $45.78 $23.8 Million - $34.4 Million	752,168 New	752,168 $23.8 Million
Q3 2023 Nov 13, 2023	SELL	$31.62 - $45.78 $20.9 Million - $30.3 Million	-662,319 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$34.58 - $46.03 $17.7 Million - $23.6 Million	511,753 Added 212.86%	752,168 $30.7 Million
Q2 2023 Aug 14, 2023	SELL	$34.58 - $46.03 $21 Million - $27.9 Million	-606,373 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$33.3 - $44.82 $23 Million - $30.9 Million	689,322 New	689,322 $25.7 Million
Q4 2022 Feb 14, 2023	BUY	$33.21 - $62.69 $28.5 Million - $53.7 Million	857,278 New	857,278 $29.9 Million
Q3 2022 Nov 13, 2023	BUY	$53.92 - $71.7 $35.7 Million - $47.5 Million	662,319 New	662,319 $37.1 Million
Q2 2022 Aug 14, 2023	BUY	$38.49 - $76.21 $23.3 Million - $46.2 Million	606,373 New	606,373 $31.4 Million
Q1 2022 May 12, 2023	SELL	$58.27 - $118.99 $20.8 Million - $42.4 Million	-356,471 Reduced 41.58%	500,807 $36.4 Million
Q1 2022 May 09, 2022	SELL	$58.27 - $118.99 $25.7 Million - $52.6 Million	-441,760 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$100.76 - $138.36 $44.5 Million - $61.1 Million	441,760 New	441,760 $52.2 Million
Q3 2021 Nov 14, 2022	BUY	$132.37 - $176.78 $81 Million - $108 Million	612,136 New	612,136 $82.1 Million
Q3 2021 Nov 05, 2021	SELL	$132.37 - $176.78 $54.9 Million - $73.3 Million	-414,719 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$60.88 - $161.91 $25.2 Million - $67.1 Million	414,719 New	414,719 $67.1 Million
Q2 2021 Aug 10, 2021	SELL	$60.88 - $161.91 $29.7 Million - $79.1 Million	-488,636 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$46.59 - $83.68 $22.8 Million - $40.9 Million	488,636 New	488,636 $39.2 Million
Q3 2020 Nov 10, 2020	SELL	$17.47 - $24.93 $262,049 - $373,950	-15,000 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$11.14 - $22.87 $167,100 - $343,050	15,000 New	15,000 $315,000

Others Institutions Holding NTLA

# of Institutions

324

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

12.5M
Shares

$123 Million
1.28% of portfolio
Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$94.3 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$94 Million
0.0% of portfolio
State Street Corp Boston, MA

5.14M
Shares

$50.4 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.95M
Shares

$48.5 Million
3.75% of portfolio

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $744M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account